/C O R R E C T I O N -- Peregrine Pharmaceuticals, Inc./

Saturday, September 8, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

In the news release, Peregrine (Nasdaq: PPHM) Reports Data ShowingBavituximab's Potential to Shrink Prostate Tumors, issued earlier today byPeregrine Pharmaceuticals, Inc. over PR Newswire, the headline should read"Peregrine Researchers Report Data Showing Bavituximab's Potential to ShrinkHuman Prostate Tumors in Model of Relapsed Disease" rather than "PeregrineReports Data Showing Bavituximab's Potential to Shrink Prostate Tumors" asincorrectly transmitted by PR Newswire.

SOURCE Peregrine Pharmaceuticals, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store